ARTICLE | Company News
IBM, Broad Institute deal
November 11, 2016 9:02 PM UTC
The Broad Institute and IBM partnered in a $50 million, five-year research initiative to evaluate drug resistance in cancer. The Broad Institute will provide tumor genome sequence data from patients w...